An advisory committee to the Centers for Disease Control and Prevention is scheduled to meet today to determine who will receive a COVID-19 vaccine first. Vaccine frontrunners Pfizer-BioNTech and Moderna have both requested Emergency Use Authorization (EUA) from the Food and Drug Administration that, if granted, would allow their vaccines to be immediately distributed and administered to people the most at risk of coronavirus infection. Priorities are expected to include front line healthcare workers, first responders, and the elderly. The FDA is scheduled to meet this month on December 10 and December 17 to consider both Pfizer-BioNTech and Moderna’s EUA requests, respectively, meaning vaccinations could begin before year’s end. Health and Human Services Secretary Alex Azar said in separate interviews Monday that he expects vaccinations “getting into people’s arms before Christmas.”